MedTrace Logo

Effectiveness of PENG Block Combined to LFCN Block on the Quality of Recovery After Total Hip Replacement

NCT04245280 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2024-08-06

No results posted yet for this study

Summary

The main objective of this study is to evaluate the effectiveness of the association of PENG and LFCN blocks on the quality of recovery 24 hours after total hip replacement surgery.

Conditions

  • Total Hip Replacement Surgery
  • Postoperative Pain

Interventions

DRUG

Ropivacaine 0.5% Injectable Solution

ropivacaine 0.5% with epinephrine 2.5 mcg/ml

DRUG

Saline Solution

normal saline solution (NaCl 0.9%)

Sponsors & Collaborators

  • Centre hospitalier de l'Université de Montréal (CHUM)

    lead OTHER

Principal Investigators

  • Sébastien Garneau, MD, FRCPC · Centre hospitalier de l'Université de Montréal (CHUM)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-04
Primary Completion
2024-07-31
Completion
2024-07-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04245280 on ClinicalTrials.gov